Addington AM, Gornick M, Duckworth J, Sporn A, Gogtay N, Bobb A, Greenstein D, Lenane M, Gochman P, Baker N, Balkissoon R, Vakkalanka RK, Weinberger DR, Rapoport JL, Straub RE. (2005) GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry. 10: 581-588.
Akbarian S, Huntsman MM, Kim JJ, Tafazzoli A, Potkin SG, Bunney WE, Jr., Jones EG. (1995) GABAA receptor subunit gene expression in human prefrontal cortex:
comparison of schizophrenics and controls. Cerebral Cortex. 5: 550-560.
Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP, Potkin SG, Sandman CA, Bunney WE, Jr., Jones EG. (1996) Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. Journal of Neuroscience. 16: 19-30.
Andreasen NC, Rezai K, Alliger R, Swayze VW, 2nd, Flaum M, Kirchner P, Cohen G, O'Leary DS. (1992) Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry. 49: 943-958.
Andreasen NC. (1996) Pieces of the schizophrenia puzzle fall into place. Neuron. 16:
697-700.
Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL, Hichwa RD. (1997) Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet. 349: 1730-1734.
Arion D, Sabatini M, Unger T, Pastor J, Alonso-Nanclares L, Ballesteros-Yanez I, Garcia Sola R, Munoz A, Mirnics K, DeFelipe J. (2006) Correlation of transcriptome profile with electrical activity in temporal lobe epilepsy. Neurobiol Dis. 22: 374-387.
Arion D, Unger T, Lewis DA, Levitt P, Mirnics K. (2007) Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry. 62: 711-721.
53
Ashdown H, Dumont Y, Ng M, Poole S, Boksa P, Luheshi GN. (2006) The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry. 11: 47-55.
Aston C, Jiang L, Sokolov BP. (2004) Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res. 77: 858-866.
Baraban SC, Tallent MK. (2004) Interneuron Diversity series: Interneuronal neuropeptides--endogenous regulators of neuronal excitability. Trends Neurosci. 27:
135-142.
Barranger JM, Novelli EA. (2001) Gene therapy for lysosomal storage disorders.
Expert Opin Biol Ther. 1: 857-867.
Becker KG. (2001) The sharing of cDNA microarray data. Nat Rev Neurosci. 2: 438- 440.
Berman KF, Zec RF, Weinberger DR. (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry. 43: 126-135.
Bertolino A, Esposito G, Callicott J, Mattay VS, Van Horn JD, Frank JA, Berman KF, Weinberger DR. (2000) Specific relationship between prefrontal neuronal N- acetylaspartate and activation of working memory cortical network in schizophrenia.
American Journal of Psychiatry. 157: 24-34.
Bertucci F, Bernard K, Loriod B, Chang YC, Granjeaud S, Birnbaum D, Nguyen C, Peck K, Jordan BR. (1999) Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. Hum Mol Genet. 8: 1715-1722.
Bourgeois J-P, Goldman-Rakic P, Rakic P. (1994) Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cerebral Cortex. 4: 78-96.
Brail LH, Jang A, Billia F, Iscove NN, Klamut HJ, Hill RP. (1999) Gene expression in individual cells: analysis using global single cell reverse transcription polymerase chain reaction (GSC RT-PCR). Mutat Res. 406: 45-54.
54
Brown MP, Grundy WN, Lin D, Cristianini N, Sugnet CW, Furey TS, Ares M, Jr., Haussler D. (2000) Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci U S A. 97: 262-267.
Brown VM, Ossadtchi A, Khan AH, Yee S, Lacan G, Melega WP, Cherry SR, Leahy RM, Smith DJ. (2002) Multiplex three-dimensional brain gene expression mapping in a mouse model of Parkinson's disease. Genome Res. 12: 868-884.
Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA, et al. (1992) Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry. 49: 935-942.
Buckholtz JW, Meyer-Lindenberg A, Honea RA, Straub RE, Pezawas L, Egan MF, Vakkalanka R, Kolachana B, Verchinski BA, Sust S, Mattay VS, Weinberger DR, Callicott JH. (2007) Allelic variation in RGS4 impacts functional and structural connectivity in the human brain. J Neurosci. 27: 1584-1593.
Bullmore ET, Woodruff PW, Wright IC, Rabe-Hesketh S, Howard RJ, Shuriquie N, Murray RM. (1998) Does dysplasia cause anatomical dysconnectivity in schizophrenia?
Schizophr Res. 30: 127-135.
Burlina A, Visentin B. (1965) Research on enzyme pathology in schizophrenic states.
1. Malate dehydrogenase of the blood. Riv Anat Patol Oncol. 27: 380-386.
Campbell DB, North JB, Hess E. (1999) Tottering mouse motor dysfunction is abolished on the Purkinje cell degeneration (pcd) mutant background. Experimental Neurology. 160: 268-278.
Campbell DB, Lange LA, Skelly T, Lieberman J, Levitt P, Sullivan PF. (2008) Association of RGS2 and RGS5 variants with schizophrenia symptom severity.
Schizophr Res. 101: 67-75.
Carninci P, Shibata Y, Hayatsu N, Itoh M, Shiraki T, Hirozane T, Watahiki A, Shibata K, Konno H, Muramatsu M, Hayashizaki Y. (2001) Balanced-size and long-size cloning of full-length, cap-trapped cDNAs into vectors of the novel lambda-FLC family allows enhanced gene discovery rate and functional analysis. Genomics. 77: 79- 90.
55
Carpenter WT, Buchanan RW. (1994) Schizophrenia. New England Journal of Medicine: 330, 681-690.
Chen CC, Chen N, Lau LF. (2001) The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem. 276: 10443-10452.
Chen X, Dunham C, Kendler S, Wang X, O'Neill FA, Walsh D, Kendler KS. (2004) Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am J Med Genet B Neuropsychiatr Genet. 129: 23-26.
Cheung VG, Gregg JP, Gogolin-Ewens KJ, Bandong J, Stanley CA, Baker L, Higgins MJ, Nowak NJ, Shows TB, Ewens WJ, Nelson SF, Spielman RS. (1998) Linkage- disequilibrium mapping without genotyping. Nat Genet. 18: 225-230.
Cheung VG, Nelson SF. (1998) Genomic mismatch scanning identifies human genomic DNA shared identical by descent. Genomics. 47: 1-6.
Cheung VG, Morley M, Aguilar F, Massimi A, Kucherlapati R, Childs G. (1999) Making and reading microarrays. Nat Genet. 21: 15-19.
Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, Bhatia T, Deshpande SN, B KT, Ferrell RE, Middleton FA, Devlin B, Levitt P, Lewis DA, Nimgaonkar VL.
(2002) Association and linkage analyses of RGS4 polymorphisms in schizophrenia.
Hum Mol Genet. 11: 1373-1380.
Chung C, Tallerico T, Seeman P. (2003) Schizophrenia hippocampus has elevated expression of chondrex glycoprotein gene. Synapse. 50: 29-34.
Chung RS, Adlard PA, Dittmann J, Vickers JC, Chuah MI, West AK. (2004) Neuron- glia communication: metallothionein expression is specifically up-regulated by astrocytes in response to neuronal injury. J Neurochem. 88: 454-461.
Cirelli C, Tononi G. (1999) Differences in brain gene expression between sleep and waking as revealed by mRNA differential display and cDNA microarray technology. J Sleep Res. 8 Suppl 1: 44-52.
Colantuoni C, Jeon OH, Hyder K, Chenchik A, Khimani AH, Narayanan V, Hoffman EP, Kaufmann WE, Naidu S, Pevsner J. (2001) Gene expression profiling in
56
postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol Dis. 8: 847-865.
Conde F, Lund JS, Jacobowitz DM, Baimbridge KG, Lewis DA. (1994) Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: distribution and morphology. J Comp Neurol. 341: 95-116.
Couve A, Kittler JT, Uren JM, Calver AR, Pangalos MN, Walsh FS, Moss SJ. (2001) Association of GABA(B) receptors and members of the 14-3-3 family of signaling proteins. Mol Cell Neurosci. 17: 317-328.
Dean B, Opeskin K, Pavey G, Hill C, Keks N. (1997) Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia. J Neural Transm. 104: 1371-1381.
DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM. (1996) Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet. 14: 457-460.
Dongre AR, Opiteck G, Cosand WL, Hefta SA. (2001) Proteomics in the post-genome age. Biopolymers. 60: 206-211.
Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA. (2005) The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys.
Neuropsychopharmacology. 30: 1649-1661.
Erdely HA, Tamminga CA, Roberts RC, Vogel MW. (2006) Regional alterations in RGS4 protein in schizophrenia. Synapse. 59: 472-479.
Evans CO, Young AN, Brown MR, Brat DJ, Parks JS, Neish AS, Oyesiku NM. (2001) Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab. 86: 3097-3107.
Farrant M, Nusser Z. (2005) Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci. 6: 215-229.
57
Fenton WS, Hibbeln J, Knable M. (2000) Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry. 47: 8- 21.
Freeman WM, Walker SJ, Vrana KE. (1999) Quantitative RT-PCR: pitfalls and potential. Biotechniques. 26:112-122, 124-115.
Fritschy JM, Mohler H. (1995) GABAA-receptor heterogeneity in the adult rat brain:
differential regional and cellular distribution of seven major subunits. J Comp Neurol.
359: 154-194.
Frodl T, Meisenzahl EM, Muller D, Greiner J, Juckel G, Leinsinger G, Hahn H, Moller HJ, Hegerl U. (2001) Corpus callosum and P300 in schizophrenia. Schizophr Res. 49:
107-119.
Garey L, Ong W, Patel T, Kanani M, Davis A, Mortimer A, Barnes T, Hirsch S. (1998) Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 65: 446-453.
Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J.
(2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5: R80.
Geschwind D, Ou J, Easterday M, Dougherty J, Jackson L, Chen Z, Antoine H, Terskikh A, Weissman I, Nelson S, Kornblum H. (2001) A genetic analysis of neural progenitor differentiation. Neuron. 29: 325-339.
Geschwind DH, Gregg J, Boone K, Karrim J, Pawlikowska-Haddal A, Rao E, Ellison J, Ciccodicola A, D'Urso M, Woods R, Rappold GA, Swerdloff R, Nelson SF. (1998) Klinefelter's syndrome as a model of anomalous cerebral laterality: testing gene dosage in the X chromosome pseudoautosomal region using a DNA microarray. Dev Genet.
23: 215-229.
Geschwind DH. (2000) Mice, microarrays, and the genetic diversity of the brain. Proc Natl Acad Sci U S A. 97: 10676-10678.
58
Geschwind DH. (2001) Sharing gene expression data: an array of options. Nat Rev Neurosci. 2: 435-438.
Gilbert AR, Rosenberg DR, Harenski K, Spencer S, Sweeney JA, Keshavan MS.
(2001) Thalamic volumes in patients with first-episode schizophrenia. Am J Psychiatry.
158: 618-624.
Ginsberg SD, Crino PB, Lee VM, Eberwine JH, Trojanowski JQ. (1997) Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques. Ann Neurol.
41: 200-209.
Ginsberg SD, Crino PB, Hemby SE, Weingarten JA, Lee VM, Eberwine JH, Trojanowski JQ. (1999) Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques. Ann Neurol. 45: 174-181.
Ginsberg SD, Hemby SE, Lee VM, Eberwine JH, Trojanowski JQ. (2000) Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol.
48: 77-87.
Giovannoni G, Baker D. (2003) Inflammatory disorders of the central nervous system.
Curr Opin Neurol. 16: 347-350.
Glantz LA, Lewis DA. (1997) Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
Archives of General Psychiatry. 54: 943-952.
Glantz LA, Lewis DA. (2000) Decreased dendritic spine density of prefrontal cortical pyramidal neurons in schizophrenia. Archives of General Psychiatry. 57: 65-73.
Gold SJ, Ni YG, Dohlman HG, Nestler EJ. (1997) Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J. Neurosci.
17: 8024-8037.
Goldman-Rakic PS. (1999) The "psychic" neuron of the cerebral cortex. Ann N Y Acad Sci. 868: 13-26.
Goldstein JM, Goodman JM, Seidman LJ, Kennedy DN, Makris N, Lee H, Tourville J, Caviness VS, Jr., Faraone SV, Tsuang MT. (1999) Cortical abnormalities in
59
schizophrenia identified by structural magnetic resonance imaging. Archives of General Psychiatry. 56: 537-547.
Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 286: 531-537.
Gonchar Y, Turney S, Price JL, Burkhalter A. (2002) Axo-axonic synapses formed by somatostatin-expressing GABAergic neurons in rat and monkey visual cortex. J Comp Neurol. 443: 1-14.
Gonzalez-Albo MC, Elston GN, DeFelipe J. (2001) The human temporal cortex:
characterization of neurons expressing nitric oxide synthase, neuropeptides and calcium-binding proteins, and their glutamate receptor subunit profiles. Cereb Cortex.
11: 1170-1181.
Gosslau A, Rensing L. (2000) Induction of Hsp68 by oxidative stress involves the lipoxygenase pathway in C6 rat glioma cells. Brain Res. 864: 114-123.
Grunblatt E, Mandel S, Maor G, Youdim MB. (2001) Gene expression analysis in N- methyl-4-phenyl-1,2,3,6- tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine. J Neurochem. 78: 1-12.
Gunthard HF, Wong JK, Ignacio CC, Havlir DV, Richman DD. (1998) Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples. AIDS Res Hum Retroviruses. 14:
869-876.
Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A. 98:
4746-4751.
Hanson DR, Gottesman, II. (2005) Theories of schizophrenia: a genetic-inflammatory- vascular synthesis. BMC Med Genet. 6: 7.
Harrison PJ. (1999) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain. 122: 593-624.
60
Hashimoto R, Straub RE, Weickert CS, Hyde TM, Kleinman JE, Weinberger DR.
(2004) Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry. 9: 299-307.
Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA. (2003) Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci. 23: 6315-6326.
Hashimoto T, Arion D, Unger T, Maldonado-Aviles JG, Morris HM, Volk DW, Mirnics K, Lewis DA. (2008a) Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry. 13: 147- 161.
Hashimoto T, Bazmi HH, Mirnics K, Wu Q, Sampson AR, Lewis DA. (2008b) Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry. 165: 479-489.
Hastie T, Tibshirani R, Eisen MB, Alizadeh AA, Levy R, Staudt LM, Chen W, Botstein D, Brown P. (2000) 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol. 1: 0003.0001-0003.0021.
Hastie T, Tibshirani R, Botstein D, Brown P. (2001) Supervised harvesting of expression trees. Genome Biol. 2: 0003.0001-0003.0012.
Hendry SH, Jones EG, Emson PC. (1984) Morphology, distribution, and synaptic relations of somatostatin- and neuropeptide Y-immunoreactive neurons in rat and monkey neocortex. J Neurosci. 4: 2497-2517.
Hendry SH, Huntsman MM, Vinuela A, Mohler H, de Blas AL, Jones EG. (1994) GABAA receptor subunit immunoreactivity in primate visual cortex: distribution in macaques and humans and regulation by visual input in adulthood. J Neurosci. 14:
2383-2401.
Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH. (1997) Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci U S A. 94: 1500-1505.
61
Highley JR, Walker MA, Esiri MM, McDonald B, Harrison PJ, Crow TJ. (2001) Schizophrenia and the frontal lobes: post-mortem stereological study of tissue volume.
Br J Psychiatry. 178: 337-343.
Hirayasu Y, Shenton ME, Salisbury DF, Dickey CC, Fischer IA, Mazzoni P, Kisler T, Arakaki H, Kwon JS, Anderson JE, Yurgelun-Todd D, Tohen M, McCarley RW.
(1998) Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am J Psychiatry. 155: 1384-1391.
Hoffman SA, Shucard DW, Harbeck RJ. (1998) The immune system can affect learning: chronic immune complex disease in a rat model. J Neuroimmunol. 86: 163- 170.
Hollingshead D, Lewis DA, Mirnics K. (2005) Platform influence on DNA microarray data in postmortem brain research. Neurobiol Dis. 18: 649-655.
Hollingshead D, Korade Z, Lewis DA, Levitt P, Mirnics K. (2006) DNA self-polymers as microarray probes improve assay sensitivity. J Neurosci Methods. 151: 216-223.
Holter NS, Maritan A, Cieplak M, Fedoroff NV, Banavar JR. (2001) Dynamic modeling of gene expression data. Proc Natl Acad Sci U S A. 98: 1693-1698.
Horvath S, Mirnics K. (2009) Breaking the gene barrier in schizophrenia. Nat Med. 15:
488-490.
Hudson C, Gotowiec A, Seeman M, Warsh J, Ross BM. (1999) Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia. Biol Psychiatry. 46: 401-405.
Husi H, Grant SG. (2001) Proteomics of the nervous system. Trends Neurosci. 24: 259- 266.
Huttenlocher P. (1979) Synaptic density in human frontal cortex - Developmental changes and effects of aging. Brain Research. 163: 195-205.
Hyman SE. (2000) The genetics of mental illness: implications for practice. Bull World Health Organ. 78: 455-463.
62
Insel TR. (2007) From animal models to model animals. Biol Psychiatry. 62, 1337- 1339.
Ishikawa M, Mizukami K, Iwakiri M, Hidaka S, Asada T. (2004) Immunohistochemical and immunoblot study of GABA(A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Neurosci Res. 50, 77-84.
Iwamoto K, Kato T. (2006) Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist. 12, 349-361.
Jahn R, Sudhof TC. (1999) Membrane fusion and exocytosis. Ann Rev Biochem. 68, 863-911.
Jensen K, Chiu CS, Sokolova I, Lester HA, Mody I. (2003) GABA transporter-1 (GAT1)-deficient mice: differential tonic activation of GABAA versus GABAB receptors in the hippocampus. J Neurophysiol. 90, 2690-2701.
Jin K, Mao XO, Eshoo MW, Nagayama T, Minami M, Simon RP, Greenberg DA.
(2001) Microarray analysis of hippocampal gene expression in global cerebral ischemia. Ann Neurol. 50, 93-103.
Johnston MV, Jeon OH, Pevsner J, Blue ME, Naidu S. (2001) Neurobiology of Rett syndrome: a genetic disorder of synapse development. Brain Dev. 23 Suppl 1, S206- 213.
Jones AL, Mowry BJ, Pender MP, Greer JM. (2005) Immune dysregulation and self- reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?
Immunol Cell Biol. 83, 9-17.
Jones KA, Tamm JA, Craig DA, Ph D, Yao W, Panico R. (2000) Signal transduction by GABA(B) receptor heterodimers. Neuropsychopharmacology. 23, S41-49.
Karson C, Griffin W, Mrak R, Sturner W, Shillcutt S, Guggenheim F. (1996) Reduced levels of synaptic proteins in the prefrontal cortex in schizophrenia. Soc Neurosci Abstr. 22, 1677.
63
Kawaguchi Y, Kubota Y. (1996) Physiological and morphological identification of somatostatin- or vasoactive intestinal polypeptide-containing cells among GABAergic cell subtypes in rat frontal cortex. J Neurosci. 16, 2701-2715.
Kawaguchi Y, Kondo S. (2002) Parvalbumin, somatostatin and cholecystokinin as chemical markers for specific GABAergic interneuron types in the rat frontal cortex. J Neurocytol. 31, 277-287.
Keshavan MS, Haas GL, Kahn CE, Aguilar E, Dick EL, Schooler NR, Sweeney JA, Pettegrew JW. (1998) Superior temporal gyrus and the course of early schizophrenia:
progressive, static, or reversible? J Psychiatr Res. 32, 161-167.
Keshavan MS, Stanley JA, Pettegrew JW. (2000) Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II. Biol Psychiatry. 48, 369- 380.
Kohler LB, Berezin V, Bock E, Penkowa M. (2003) The role of metallothionein II in neuronal differentiation and survival. Brain Res. 992, 128-136.
Kozal MJ, Shah N, Shen N, Yang R, Fucini R, Merigan TC, Richman DD, Morris D, Hubbell E, Chee M, Gingeras TR. (1996) Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nat Med. 2, 753-759.
Kubota Y, Hattori R, Yui Y. (1994) Three distinct subpopulations of GABAergic neurons in rat frontal agranular cortex. Brain Res. 649, 159-173.
Kulynych JJ, Vladar K, Jones DW, Weinberger DR. (1996) Superior temporal gyrus volume in schizophrenia: a study using MRI morphometry assisted by surface rendering. Am J Psychiatry. 153, 50-56.
Kwon JS, McCarley RW, Hirayasu Y, Anderson JE, Fischer IA, Kikinis R, Jolesz FA, Shenton ME. (1999) Left planum temporale volume reduction in schizophrenia. Arch Gen Psychiatry. 56, 142-148.
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange- Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough
64
R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, Szustakowki J. (2001) Initial sequencing and analysis of the human genome.
Nature. 409, 860-921.
65
Lane HY, Liu YC, Huang CL, Chang YC, Wu PL, Huang CH, Tsai GE. (2008) RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia. J Clin Psychopharmacol. 28, 64-68.
Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS. (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell. 120, 701-713.
Lepre J, Rice JJ, Tu Y, Stolovitzky G. (2004) Genes@Work: an efficient algorithm for pattern discovery and multivariate feature selection in gene expression data.
Bioinformatics. 20, 1033-1044.
Lewin AR, Reid LE, McMahon M, Stark GR, Kerr IM. (1991) Molecular analysis of a human interferon-inducible gene family. Eur J Biochem. 199, 417-423.
Lewis D, Lieberman J. (2000) Catching up with schizophrenia: Natural history and neurobiology. Neuron. 28, 325-334.
Lewis DA, Pierri JN, Volk DW, Melchitzky DS, Woo TU. (1999) Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry. 46, 616-626.
Lewis DA. (2000) Is there a neuropathology of schizophrenia? The Neuroscientist. 6, 208-218.
Lewis DA, Hashimoto T, Volk DW. (2005a) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci. 6, 312-324.
Lewis DA, Levitt P, Mirnics K. (2005b) Gene expression changes in schizophrenia:
How do they arise? What do they mean? Clin Neurosci Res. 5, 15-21.
Lewohl JM, Wang L, Miles MF, Zhang L, Dodd PR, Harris RA. (2000) Gene expression in human alcoholism: microarray analysis of frontal cortex. Alcohol Clin Exp Res. 24, 1873-1882.
Lewohl JM, Dodd PR, Mayfield RD, Harris RA. (2001) Application of DNA microarrays to study human alcoholism. J Biomed Sci. 8, 28-36.
Lipska BK, Mitkus S, Caruso M, Hyde TM, Chen J, Vakkalanka R, Straub RE, Weinberger DR, Kleinman JE. (2006) RGS4 mRNA expression in postmortem human